Jorge Aparicio
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans J, Sylvester R, Anson-Cartwright L, Glicksman R, Hamilton R, Hahn E, Daugaard G, Lauritsen J, Wagner T, Avuzzi B, Nicolai N, del Muro X, Aparicio J, Stalder O, Rothermundt C, Fischer S, Laguna M. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office. Eur Urol Oncol 2023
Nov 9, 2023Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Nov 9, 2023Eur Urol Oncol 2023
Boormans Joost L, Sylvester Richard, Anson-Cartwright Lynn, Glicksman Rachel M, Hamilton Robert J, Hahn Ezra, Daugaard Gedske, Lauritsen Jakob, Wagner Thomas, Avuzzi Barbara, Nicolai Nicola, del Muro Xavier Garcia, Aparicio Jorge, Stalder Odile, Rothermundt Christian, Fischer Stefanie, Laguna Maria P
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma
Fischer S, Langberg C, Ståhl O, Fankhauser C, Hamid A, Koutsoukos K, Shamash J, White J, Bokemeyer C, Beyer J, Gillessen Sommer S, Wheater M, Hentrich M, Heidenreich A, Tandstad T, Cohn-Cedermark G, Thibault C, Vincenzi B, Klingbiel D, Albany C, Necchi A, Terbuch A, Lorch A, Aparicio J, Global Germ-Cell Cancer Group. Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma. J Clin Oncol 2019:JCO1901876.
Dec 26, 2019Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma
Dec 26, 2019J Clin Oncol 2019:JCO1901876
Fischer Stefanie, Langberg Carl W, Ståhl Olof, Fankhauser Christian Daniel, Hamid Anis A, Koutsoukos Konstantinos, Shamash Jonathan, White Jeff, Bokemeyer Carsten, Beyer Jörg, Gillessen Sommer Silke, Wheater Matthew, Hentrich Marcus, Heidenreich Axel, Tandstad Torgrim, Cohn-Cedermark Gabriella, Thibault Constance, Vincenzi Bruno, Klingbiel Dirk, Albany Costantine, Necchi Andrea, Terbuch Angelika, Lorch Anja, Aparicio Jorge, Global Germ-Cell Cancer Group
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
Fischer S, Cohn-Cedermark G, Ståhl O, Chau C, Arriola E, Marti K, Hutton P, Laguerre B, Maroto P, Beyer J, Dieckmann K, Lorch A, Tandstad T, Wheater M, Porfiri E, Flechon A, Aparicio J, Klingbiel D, Skrbinc B, Basso U, Shamash J, Gillessen Sommer S. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma. J Clin Oncol 2016; 35:194-200.
Nov 28, 2016Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
Nov 28, 2016J Clin Oncol 2016; 35:194-200
Fischer Stefanie, Cohn-Cedermark Gabriella, Ståhl Olof, Chau Caroline, Arriola Edurne, Marti Kalena, Hutton Paul, Laguerre Brigitte, Maroto Pablo, Beyer Jörg, Dieckmann Klaus-Peter, Lorch Anja, Tandstad Torgrim, Wheater Matthew, Porfiri Emilio, Flechon Aude, Aparicio Jorge, Klingbiel Dirk, Skrbinc Breda, Basso Umberto, Shamash Jonathan, Gillessen Sommer Silke